Proteintech, a renowned leader in antibodies and life science solutions, has unveiled Able AI, a groundbreaking artificial intelligence tool now accessible on ptglab.com. This tool is designed to assist researchers in navigating the extensive range of antibody products available.
Finding the most suitable antibodies from the vast pool of potential products is a challenge. Able helps scientists pinpoint the right antibody based on their research needs, while also providing all relevant information and associated scientific knowledge. Furthermore, it offers detailed guidance on product-specific experimental procedures, significantly reducing the time spent on planning and product selection.
This launch follows Proteintech's successful introduction of 3D Epitope Mapping earlier in the year, which enhanced researchers' capabilities to visualize antibody binding sites through experimental and AI-powered modeling. This advancement minimizes guesswork and trial-and-error, allowing scientists to design experiments and develop products with increased precision.
“Able represents the next phase in our mission to empower scientists,” said Dr. Jason Li, CEO of Proteintech. “Building on the success of our 3D Epitope Mapping platform, Able delivers tailored product recommendations and experimental design support, allowing researchers to focus more on their cutting-edge discoveries. Proteintech strives to push boundaries in the reagent world for better science and better service for every customer.”
Able is available immediately and free to use at ptglab.com or directly at www.ptglab.com/Able.
About Proteintech
Founded in 2001, Proteintech Group Inc. is a leading manufacturer of antibodies, proteins, nanobodies, and immunoassays. With the largest proprietary portfolio of self-manufactured antibodies covering two-thirds of the human proteome, Proteintech offers over 300,000 products across various research areas. Additionally, the company produces human-expressed, bioactive, cGMP-grade cytokines and growth factors. Proteintech is certified under ISO13485 and ISO9001 standards.
For more information, visit ptglab.com.
Proteintech, a renowned leader in antibodies and life science solutions, has unveiled Able AI, a groundbreaking artificial intelligence tool now accessible on ptglab.com. This tool is designed to assist researchers in navigating the extensive range of antibody products available.
Finding the most suitable antibodies from the vast pool of potential products is a challenge. Able helps scientists pinpoint the right antibody based on their research needs, while also providing all relevant information and associated scientific knowledge. Furthermore, it offers detailed guidance on product-specific experimental procedures, significantly reducing the time spent on planning and product selection.
This launch follows Proteintech's successful introduction of 3D Epitope Mapping earlier in the year, which enhanced researchers' capabilities to visualize antibody binding sites through experimental and AI-powered modeling. This advancement minimizes guesswork and trial-and-error, allowing scientists to design experiments and develop products with increased precision.
“Able represents the next phase in our mission to empower scientists,” said Dr. Jason Li, CEO of Proteintech. “Building on the success of our 3D Epitope Mapping platform, Able delivers tailored product recommendations and experimental design support, allowing researchers to focus more on their cutting-edge discoveries. Proteintech strives to push boundaries in the reagent world for better science and better service for every customer.”
Able is available immediately and free to use at ptglab.com or directly at www.ptglab.com/Able.
About Proteintech
Founded in 2001, Proteintech Group Inc. is a leading manufacturer of antibodies, proteins, nanobodies, and immunoassays. With the largest proprietary portfolio of self-manufactured antibodies covering two-thirds of the human proteome, Proteintech offers over 300,000 products across various research areas. Additionally, the company produces human-expressed, bioactive, cGMP-grade cytokines and growth factors. Proteintech is certified under ISO13485 and ISO9001 standards.
For more information, visit ptglab.com.